Organigram Global (OGI) Cash & Equivalents (2018 - 2025)

Organigram Global (OGI) has reported Cash & Equivalents for 8 consecutive years, with $20.5 million the latest figure, recorded in Q3 2025.

• On a quarterly basis, Cash & Equivalents fell 73.81% year-over-year to $20.5 million in Q3 2025; TTM through Sep 2025 was $20.5 million, a 73.81% decrease from a year earlier, with the FY2025 full-year figure at $20.2 million, down 74.29% from the prior year.
• Cash & Equivalents was $20.5 million for Q3 2025 at Organigram Global, up from $3.4 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $78.2 million in Q3 2024 and troughed at $687000.0 in Q4 2021.
• A 5-year average of $33.5 million and a median of $34.9 million in 2023 frame the typical range for Cash & Equivalents.
• The widest YoY moves for Cash & Equivalents: up 645.15% in 2021, down 99.34% in 2021.
• Over 5 years, Cash & Equivalents stood at $687000.0 in 2021, then soared by 7644.27% to $53.2 million in 2022, then slipped by 27.43% to $38.6 million in 2023, then plunged by 90.5% to $3.7 million in 2024, then soared by 458.74% to $20.5 million in 2025.
• The last three Cash & Equivalents figures came in at $20.5 million (Q3 2025), $3.4 million (Q1 2025), and $3.7 million (Q4 2024), per Business Quant data.